{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:31:57Z","timestamp":1789468317207,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673627"],"award-info":[{"award-number":["81673627"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673717"],"award-info":[{"award-number":["81673717"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81774199"],"award-info":[{"award-number":["81774199"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010843","name":"Guangzhou Science, Technology and Innovation Commission","doi-asserted-by":"publisher","award":["201803010047"],"award-info":[{"award-number":["201803010047"]}],"id":[{"id":"10.13039\/501100010843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010843","name":"Guangzhou Science, Technology and Innovation Commission","doi-asserted-by":"publisher","award":["201805010005"],"award-info":[{"award-number":["201805010005"]}],"id":[{"id":"10.13039\/501100010843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.intimp.2019.05.036","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T04:56:08Z","timestamp":1565240168000},"page":"105651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"special_numbering":"C","title":["Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson's disease mouse model"],"prefix":"10.1016","volume":"75","author":[{"given":"Cong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousheng","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erjin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renrong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weirong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoluu","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huafeng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.05.036_bb0005","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1017\/S1462399409001148","article-title":"Molecular pathogenesis of Parkinson disease: insights from genetic studies","volume":"11","author":"Gasser","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2019.05.036_bb0010","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","article-title":"Neuroinflammation in Parkinson's disease","volume":"18","author":"Hirsch","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.intimp.2019.05.036_bb0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41531-017-0032-2","article-title":"Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson's disease","volume":"3","author":"Sarkar","year":"2017","journal-title":"NPJ Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.intimp.2019.05.036_bb0020","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12974-016-0643-2","article-title":"Gas1 up-regulation is inducible and contributes to cell apoptosis in reactive astrocytes in the substantia nigra of LPS and MPTP models","volume":"13","author":"Sun","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.intimp.2019.05.036_bb0025","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/glia.22479","article-title":"NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration","volume":"61","author":"Qin","year":"2013","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.intimp.2019.05.036_bb0030","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neuint.2012.12.016","article-title":"Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson's disease","volume":"62","author":"Taylor","year":"2013","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.intimp.2019.05.036_bb0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jcp.26865","article-title":"Oxidative stress and neuroinflammation in the story of Parkinson's disease: could targeting these pathways write a good ending?","volume":"234","author":"Hassanzadeh","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2019.05.036_bb0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson's disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl. Neurodegener."},{"issue":"4","key":"10.1016\/j.intimp.2019.05.036_bb0045","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"issue":"7434","key":"10.1016\/j.intimp.2019.05.036_bb0050","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2019.05.036_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.nbd.2018.05.016","article-title":"Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury","volume":"117","author":"Xu","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2019.05.036_bb0060","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2016.04.200","article-title":"Energy metabolism and inflammation in brain aging and Alzheimer's disease","volume":"100","author":"Yin","year":"2016","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.intimp.2019.05.036_bb0065","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1007\/s12035-016-9980-5","article-title":"Caspase-1 deficiency alleviates dopaminergic neuronal death via inhibiting Caspase-7\/AIF pathway in MPTP\/p mouse model of Parkinson's disease","volume":"54","author":"Qiao","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.intimp.2019.05.036_bb0070","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s11481-017-9746-5","article-title":"Involvement of c-Abl kinase in microglial activation of NLRP3 Inflammasome and impairment in autolysosomal system","volume":"12","author":"Lawana","year":"2017","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2019.05.036_bb0075","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12974-017-1036-x","article-title":"Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia","volume":"14","author":"Fan","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.intimp.2019.05.036_bb0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12974-018-1236-z","article-title":"Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP\/p mouse model of Parkinson's disease","volume":"15","author":"Qiao","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.intimp.2019.05.036_bb0085","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1089\/ars.2015.6615","article-title":"Nuclear factor E2-related factor-2 negatively regulates NLRP3 inflammasome activity by inhibiting reactive oxygen species-induced NLRP3 priming","volume":"26","author":"Liu","year":"2017","journal-title":"Antioxid. Redox Signal."},{"issue":"11","key":"10.1016\/j.intimp.2019.05.036_bb0090","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s12272-016-0827-4","article-title":"Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance","volume":"39","author":"Yu","year":"2016","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.intimp.2019.05.036_bb0095","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.redox.2018.07.002","article-title":"Polydatin prevents fructose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate Keap1\/Nrf2 pathway","volume":"18","author":"Zhao","year":"2018","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.intimp.2019.05.036_bb0100","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/pr.117.014753","article-title":"Transcription factor NRF2 as a therapeutic target for chronic diseases: a systems medicine approach","volume":"70","author":"Cuadrado","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.intimp.2019.05.036_bb0105","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s13075-015-0844-6","article-title":"Citral alleviates an accelerated and severe lupus nephritis model by inhibiting the activation signal of NLRP3 inflammasome and enhancing Nrf2 activation","volume":"17","author":"Ka","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"12","key":"10.1016\/j.intimp.2019.05.036_bb0110","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.jnutbio.2013.07.009","article-title":"DSS-induced acute colitis in C57BL\/6 mice is mitigated by sulforaphane pre-treatment","volume":"24","author":"Wagner","year":"2013","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.intimp.2019.05.036_bb0115","doi-asserted-by":"crossref","first-page":"32206","DOI":"10.1038\/srep32206","article-title":"Sulforaphane protects against rotenone-induced neurotoxicity in vivo: involvement of the mTOR, Nrf2, and autophagy pathways","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2019.05.036_bb0120","first-page":"847","article-title":"Sulforaphane protects against 6-hydroxydopamine-induced cytotoxicity by increasing expression of heme oxygenase-1 in a PI3K\/Akt-dependent manner","volume":"5","author":"Deng","year":"2012","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2019.05.036_bb0125","first-page":"215","article-title":"Inhibition of 6-hydroxydopamine-induced endoplasmic reticulum stress by sulforaphane through the activation of Nrf2 nuclear translocation","volume":"6","author":"Deng","year":"2012","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2019.05.036_bb0130","first-page":"169","article-title":"Nrf2 activation attenuates the early suppression of mitochondrial respiration due to the alpha-synuclein overexpression","volume":"41","author":"Fu","year":"2018","journal-title":"Biom. J."},{"issue":"1","key":"10.1016\/j.intimp.2019.05.036_bb0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jbt.20053","article-title":"Potential neuroprotective effect of t-butylhydroquinone against neurotoxicity-induced by 1-methyl-4-(2\u2032-methylphenyl)-1,2,3,6-tetrahydropyridine (2\u2032-methyl-MPTP) in mice","volume":"19","author":"Abdel-Wahab","year":"2005","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"7","key":"10.1016\/j.intimp.2019.05.036_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021907","article-title":"NRF2 activation restores disease related metabolic deficiencies in olfactory neurosphere-derived cells from patients with sporadic Parkinson's disease","volume":"6","author":"Cook","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2019.05.036_bb0145","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neulet.2016.12.046","article-title":"Astragaloside IV attenuates cognitive impairments induced by transient cerebral ischemia and reperfusion in mice via anti-inflammatory mechanisms","volume":"639","author":"Li","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2019.05.036_bb0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11010-011-1219-1","article-title":"Astragaloside IV prevents MPP(+)-induced SH-SY5Y cell death via the inhibition of Bax-mediated pathways and ROS production","volume":"364","author":"Zhang","year":"2012","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.intimp.2019.05.036_bb0155","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s12035-016-9874-6","article-title":"Astragaloside IV, a natural PPARgamma agonist, reduces Abeta production in Alzheimer's disease through inhibition of BACE1","volume":"54","author":"Wang","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2019.05.036_bb0160","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.freeradbiomed.2013.02.027","article-title":"Astragaloside IV suppresses collagen production of activated hepatic stellate cells via oxidative stress-mediated p38 MAPK pathway","volume":"60","author":"Li","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"10","key":"10.1016\/j.intimp.2019.05.036_bb0165","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/aps.2017.208","article-title":"Astragaloside IV ameliorates neuroinflammation-induced depressive-like behaviors in mice via the PPARgamma\/NF-kappaB\/NLRP3 inflammasome axis","volume":"39","author":"Song","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"7\u20138","key":"10.1016\/j.intimp.2019.05.036_bb0170","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/10715762.2017.1361532","article-title":"Renoprotective mechanisms of Astragaloside IV in cisplatin-induced acute kidney injury","volume":"51","author":"Yan","year":"2017","journal-title":"Free Radic. Res."},{"issue":"3","key":"10.1016\/j.intimp.2019.05.036_bb0175","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bbrc.2015.01.002","article-title":"EGFR mediates astragaloside IV-induced Nrf2 activation to protect cortical neurons against in vitro ischemia\/reperfusion damages","volume":"457","author":"Gu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2019.05.036_bb0180","doi-asserted-by":"crossref","first-page":"327294","DOI":"10.1155\/2014\/327294","article-title":"Danggui-Shaoyao-San improves learning and memory in female SAMP8 via modulation of estradiol","volume":"2014","author":"Huang","year":"2014","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"6","key":"10.1016\/j.intimp.2019.05.036_bb0185","first-page":"5569","article-title":"Neuroprotective effects of astragaloside IV on Parkinson disease models of mice and primary astrocytes","volume":"14","author":"Xia","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2019.05.036_bb0190","doi-asserted-by":"crossref","first-page":"3571604","DOI":"10.1155\/2018\/3571604","article-title":"Bushen-Yizhi formula alleviates neuroinflammation via inhibiting NLRP3 inflammasome activation in a mouse model of Parkinson's disease","volume":"2018","author":"Mo","year":"2018","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"15","key":"10.1016\/j.intimp.2019.05.036_bb0195","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1089\/scd.2014.0489","article-title":"Thyroid hormone-Otx2 signaling is required for embryonic ventral midbrain neural stem cells differentiated into dopamine neurons","volume":"24","author":"Chen","year":"2015","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.intimp.2019.05.036_bb0200","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuropharm.2015.04.037","article-title":"alpha-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease","volume":"97","author":"Kim","year":"2015","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.intimp.2019.05.036_bb0205","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease","volume":"164","author":"Duty","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2019.05.036_bb0210","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2174\/138161211795164095","article-title":"The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease","volume":"17","author":"Prediger","year":"2011","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.intimp.2019.05.036_bb0215","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jcp.26865","article-title":"Oxidative stress and neuroinflammation in the story of Parkinson's disease: could targeting these pathways write a good ending?","volume":"234","author":"Hassanzadeh","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2019.05.036_bb0220","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41418-018-0124-5","article-title":"MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration","volume":"26","author":"Lee","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2019.05.036_bb0225","series-title":"Bushen-Yizhi Formula Alleviates Neuroinflammation Via Inhibiting NLRP3 Inflammasome Activation in a Mouse Model of Parkinson's Disease","author":"Mo","year":"2018"},{"issue":"7","key":"10.1016\/j.intimp.2019.05.036_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/genes9070357","article-title":"Genetic targeting of GRP78 in the VMH improves obesity independently of food intake","volume":"9","author":"Linares-Pose","year":"2018","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.intimp.2019.05.036_bb0235","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.redox.2017.03.001","article-title":"Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK\/GSK3beta-Nrf2 signal axis","volume":"12","author":"Lv","year":"2017","journal-title":"Redox Biol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919302218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919302218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T03:15:06Z","timestamp":1749525306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919302218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":47,"alternative-id":["S1567576919302218"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.05.036","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson's disease mouse model","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.05.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105651"}}